HIV 1 News and Research

RSS

Simple low-cost intervention could help reduce HIV-related deaths in Africa

A new approach to care for patients with advanced HIV in Tanzania and Zambia, combining community support and screening for a type of meningitis, has reduced deaths by 28%.

11 Mar 2015

Salk scientists move one step closer to creating drug that could prevent HIV virus

Imagine a single drug that could prevent human immunodeficiency virus (HIV) infection, treat patients who have already contracted HIV, and even remove all the dormant copies of the virus from those with the more advanced disease. It sounds like science fiction, but Salk scientists have gotten one step closer to creating such a drug by customizing a powerful defense system used by many bacteria and training this scissor-like machinery to recognize the HIV virus.

10 Mar 2015

Clinical study launched to evaluate effectiveness of new HCV therapy in Washington, D.C.

Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection.

9 Mar 2015

Scientists design a promising vaccine for herpes viruses

Herpes simplex virus infections are an enormous global health problem and there is currently no viable vaccine.

9 Mar 2015

New type of vaccine holds promise for prevention of genital herpes

Scientists at Albert Einstein College of Medicine of Yeshiva University have designed a new type of vaccine that could be the first-ever for preventing genital herpes--one of the most common sexually transmitted diseases, affecting some 500 million people worldwide.

9 Mar 2015

Women for Positive Action introduces new educational tool for women living with HIV

To mark International Women's Day (March 8, 2015), Women for Positive Action has launched a practical and informative new educational tool entitled 'Hepatitis and coinfection in women living with HIV'. Led by a global, multidisciplinary group of experts, Women for Positive Action is committed to addressing the specific concerns of women living with HIV.

6 Mar 2015

Finding may help advance experimental approach to improving public health

Scientists have discovered a new way to manipulate how cells function, a finding that might help advance an experimental approach to improving public health: DNA vaccines, which could be more efficient, less expensive and easier to store than traditional vaccines.

5 Mar 2015

Researchers find new retrovirus 'fossil' in vampire bats

Scientists discovered a new retrovirus "fossil" found in the common vampire bat which is homologous to retroviruses in rodents and primates. The results suggest the recent circulation of an active infectious retrovirus and cross-species transmission.

4 Mar 2015

New conference to discuss ways of abolishing female genital mutilation in the UK

'We believe that education is the way forward to eradicate FGM. Therefore, in this symposium we are also launching an educational package for both professionals and communities alike'- Sadiyo Siad, FGM survivor, activist and campaigner.

4 Mar 2015

Scientists find gorilla origins in two human AIDS virus lineages

Two of the four known groups of human AIDS viruses (HIV-1 groups O and P) have originated in western lowland gorillas, according to an international team of scientists from the Perelman School of Medicine at the University of Pennsylvania, the University of Montpellier, the University of Edinburgh, and others.

3 Mar 2015

New study examines risk factors for use of synthetic marijuana among teens

Synthetic cannabinoids ("synthetic marijuana"), with names like Spice, K2, Scooby Doo and hundreds of others, are often sold as a "legal" alternative to marijuana. Often perceived as a safe legal alternative to illicit drug use, synthetic marijuana use was associated with 11,561 reports of poisonings in the United States between January 2009 and April 2012.

3 Mar 2015

Nottingham researchers developing mobile phone app that could help identify premature babies

A mobile phone app that will identify babies born prematurely in the developing world is being developed by researchers at The University of Nottingham.

2 Mar 2015

Findings may explain why HIV cure strategies have failed

A major hurdle to curing people of HIV infection is the way the virus hides in a reservoir composed primarily of dormant immune cells.

2 Mar 2015

WuXi applauds TaiMed for receiving FDA breakthrough therapy designation for ibalizumab

WuXi PharmaTech (Cayman) Inc., a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, congratulates our partner TaiMed Biologics for receiving breakthrough therapy designation from the U.S. FDA for ibalizumab (TMB355).

28 Feb 2015

New research reveals that HIV latency is controlled by the virus itself

New research from the Gladstone Institutes for the first time provides strong evidence that HIV latency is controlled not by infected host cells, but by the virus itself. This fundamentally changes how scientists perceive latency, presenting it as an evolutionarily advantageous phenomenon rather than a biological accident.

27 Feb 2015

UMass Amherst biologist partners with Chinese scientist to develop novel drug platform

Margaret Riley, an evolutionary biologist at the University of Massachusetts Amherst and pioneer in fighting antibiotic-resistant bacteria, announced this week that she is partnering with a Chinese scientist to develop a new drug platform, pheromonicins. The Chinese government is committing $400 million per year to support the newly created Pheromonicin Institute of Beijing.

26 Feb 2015

Study shows how financial incentives can influence some HIV-positive patients in clinical settings

A new study by the HIV Prevention Trials Network shows that some HIV-positive patients were motivated by financial incentives to take their HIV antiretroviral therapy (ART) medication regularly and maintain control of their HIV - enhancing their own health benefits and reducing the chance of passing the virus on to others.

25 Feb 2015

bioLytical receives FDA approval for INSTI HIV Antibody Test

bioLytical Laboratories Inc., a leading manufacturer of point-of-care rapid diagnostic tests, announced today that it has received U.S. Food and Drug Administration approval of its INSTI HIV Antibody Test for use in detecting antibodies to HIV type 2 (HIV-2).

24 Feb 2015

MPP, MSD sign licensing agreement for paediatric formulations of raltegravir

The Medicines Patent Pool announced a licence today with MSD, known as Merck in the United States and Canada, for paediatric formulations of raltegravir, a key medicine approved for children living with HIV four weeks of age and older.

24 Feb 2015

Mylan to distribute Sovaldi and Harvoni tablets in India for treatment of chronic hepatitis C

Mylan Inc. today announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India.

23 Feb 2015

HIV 1 News and Research

Simple low-cost intervention could help reduce HIV-related deaths in Africa

Salk scientists move one step closer to creating drug that could prevent HIV virus

Clinical study launched to evaluate effectiveness of new HCV therapy in Washington, D.C.

Scientists design a promising vaccine for herpes viruses

New type of vaccine holds promise for prevention of genital herpes

Women for Positive Action introduces new educational tool for women living with HIV

Finding may help advance experimental approach to improving public health

Researchers find new retrovirus 'fossil' in vampire bats

New conference to discuss ways of abolishing female genital mutilation in the UK

Scientists find gorilla origins in two human AIDS virus lineages

New study examines risk factors for use of synthetic marijuana among teens

Nottingham researchers developing mobile phone app that could help identify premature babies

Findings may explain why HIV cure strategies have failed

WuXi applauds TaiMed for receiving FDA breakthrough therapy designation for ibalizumab

New research reveals that HIV latency is controlled by the virus itself

UMass Amherst biologist partners with Chinese scientist to develop novel drug platform

Study shows how financial incentives can influence some HIV-positive patients in clinical settings

bioLytical receives FDA approval for INSTI HIV Antibody Test

MPP, MSD sign licensing agreement for paediatric formulations of raltegravir

Mylan to distribute Sovaldi and Harvoni tablets in India for treatment of chronic hepatitis C

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News